FINCH THERAPEUTICS GROUP, INC. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f6a7a443-cf9f-49ec-99ee-b870c00048f0/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $107.0k | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-035952 |
| FY 2022 | $861.0k | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-009490 |
| FY 2021 | $18.5M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-005243 |
| FY 2020 | $7.7M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-005243 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
FINCH THERAPEUTICS GROUP, INC. — all facts · Net Income · Operating Income